Indoco Remedies Ltd Board of Directors
Board of Directors at Indoco Remedies Ltd
Independent Non Exe. Director
Managing Director
Independent Non Exe. Director
Non Executive Director
Company Sec. & Compli. Officer
Key Highlights
- Suresh G Kare joins the board as Chairman & Non Executive Dir., in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Aditi Kare Panandikar joins the board as ED / MD / Promoter, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Sundeep V Bambolkar joins the board as Joint MD & Executive Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Anand Nadkarni joins the board as Non-Exec & Non-Independent Dir, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Satish Shenoy joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Indoco Remedies Ltd
NSE: INDOCO
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 30 Jan 2026 | 217.4 |
| 29 Jan 2026 | 212.9 |
| 28 Jan 2026 | 216.45 |
| 27 Jan 2026 | 220.25 |
| 23 Jan 2026 | 210.2 |
| 22 Jan 2026 | 214.95 |
| 21 Jan 2026 | 206.95 |
| 20 Jan 2026 | 208.05 |
| 19 Jan 2026 | 214.15 |
| 16 Jan 2026 | 218.7 |
Company Fundamentals for Indoco Remedies Ltd
Market Cap
2,005 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
2.0
Day’s High
227.9
Day’s Low
212.55
DTE
1.0
ROE
-11.3
52 Week High
348.1
52 Week Low
190.0
ROCE
-2.1
Market Price of Indoco Remedies Ltd
1M
1Y
3Y
5Y
Indoco Remedies Ltd News Hub
Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg
Indoco Remedies announced the receipt of final approval from the USFDA for Abbreviated New Drug Appl
Read more
21 Aug 24
Indoco Remedies spurts on receiving USFDA nod for Lofexidine tablets
The generic equivalent of Lucemyra Tablets will market to USWM, LLC. 'Indoco has been granted a Comp
Read more
21 Aug 24
Indoco Remedies fixes record date for final dividend
Indoco Remedies has fixed 19 September 2024 as record date for determining entitlement of members to
Read more
30 Aug 24
Indoco Remedies AGM scheduled
Indoco Remedies announced that the Annual General Meeting (AGM) of the company will be held on 26 Se
Read more
31 Aug 24
